Related Experiment Video

Updated: Jun 6, 2026

An Adapted Optical Density-Based Microplate Assay for Characterizing Actinobacteriophage Infection
03:33

An Adapted Optical Density-Based Microplate Assay for Characterizing Actinobacteriophage Infection

Published on: June 30, 2023

Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection

Julia Garbe1, Andrea Wesche, Boyke Bunk

  • 1Institute of Microbiology, Technische Universität Braunschweig, Spielmannstr, 7, 38106 Braunschweig, Germany.

BMC Microbiology
|November 30, 2010
PubMed
Abstract

Insights

Phage therapy offers an alternative for chronic Pseudomonas aeruginosa lung infections in Cystic Fibrosis patients. Phage JG024 effectively infects P. aeruginosa, but alginate production hinders its efficacy in simulated lung infections.

Area of Science:

  • Microbiology
  • Bacteriology
  • Virology

Background:

  • Pseudomonas aeruginosa is a major cause of chronic lung infections in Cystic Fibrosis (CF) patients.
  • Antibiotic treatment is often ineffective against established P. aeruginosa infections.
  • Bacteriophage therapy presents a potential alternative for treating these infections.

Purpose of the Study:

  • To isolate and characterize broad-host-range phages targeting P. aeruginosa.
  • To investigate factors influencing phage infectivity under simulated chronic lung infection conditions.

Main Methods:

  • Isolation and genomic characterization of bacteriophage JG024.
  • Determination of phage JG024 receptor (lipopolysaccharide).
  • Infection assays using an artificial sputum medium to simulate chronic lung infection.

Main Results:

  • Phage JG024 exhibits broad-host-range activity against clinical and environmental P. aeruginosa strains.
  • JG024 is a PB1-like phage, with lipopolysaccharide as its receptor.
  • Alginate production by P. aeruginosa significantly reduces phage JG024 infectivity.

Conclusions:

  • Phage JG024 is a promising candidate for phage therapy against P. aeruginosa infections.
  • Alginate, a key component of the CF lung environment, impairs phage efficacy.
  • Further research is needed to optimize phage therapy in the context of P. aeruginosa biofilm formation.

More Related Videos

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants11:35

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants

Published on: May 4, 2018

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins09:40

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins

Published on: June 11, 2015

Related Concept Videos

DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Bacteriophages of the Human Virome01:23

Bacteriophages of the Human Virome

Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...